ZNTL

Latest SEC Filings & News for ZNTL

1 most recent filing and news item mentioning ZNTL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ZNTL/news?limit=20"

Pull ZNTL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryMay 21, 2026Positive

Zentalis announces Phase 1b MUIR trial data for azenosertib plus paclitaxel in ovarian cancer

Zentalis Pharmaceuticals presented Phase 1b MUIR trial results showing 39% overall response rate and 7.3-month median PFS for azenosertib combined with paclitaxel in platinum-resistant ovarian cancer patients. The data demonstrates a manageable safety profile and supports continu

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.